Molecular Therapy-Oncolytics

Article	Citations
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities	98
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect	93
Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism	89
Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer	77
ENO1 and Cancer	76
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications	70
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B	62
Carboranes as unique pharmacophores in antitumor medicinal chemistry	61
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy	60
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?	55
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer	52
The next wave of cellular immunotherapies in pancreatic cancer	52
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma	51
Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges	51
Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression	48
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma	46
Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor	45
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma	45
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation	44
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy	44
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy	44
Novel roles of METTL1/WDR4 in tumor via m7G methylation	42
Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma	41
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy	41
Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways	41

Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives	39
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma	38
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis	38
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials	38
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma	36
Defueling the cancer: ATP synthase as an emerging target in cancer therapy	36
A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy	35
Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer	35
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer	35
Angiogenesis-related non-coding RNAs and gastrointestinal cancer	35
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice	35
m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer	33
SNHG1 knockdown upregulates miR-376a and downregulates FOXK1/Snail axis to prevent tumor growth and metastasis in HCC	33
Regulatory role and mechanism of m6A RNA modification in human metabolic diseases	33
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin	32
m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer	31
A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy	31
BRD4: An emerging prospective therapeutic target in glioma	31
Genetic variants in m6A modification core genes are associated with glioma risk in Chinese children	30
microRNA-130b-3p contained in MSC-derived EVs promotes lung cancer progression by regulating the FOXO3/NFE2L2/TXNRD1 axis	30
Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis	30
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform	29
Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas	29
Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis	28
Systematic review of the immunological landscape of Wilms tumors	28
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges	28
MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC	28
Classification of pediatric gliomas based on immunological profiling: Implications for immunotherapy strategies	27
Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma	27
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2	27
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis	27
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy	26
Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma	25
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma	25
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?	25
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma	25
Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes	25
lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1	24
Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer	24
Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting desmocollin-2	24
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4	24
The lncRNA DLGAP1-AS1/miR-149-5p/TGFB2 axis contributes to colorectal cancer progression and 5-FU resistance by regulating smad2 pathway	23
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment	23
Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway	22
Imaging CAR T-cell kinetics in solid tumors: Translational implications	22
Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer	22
The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer	22
Current strategies in engaging oncolytic viruses with antitumor immunity	22
Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma	22
A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer	21

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives	21
Fluorescent imaging for cancer therapy and cancer gene therapy	21
AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines	21
LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma	21
lncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through PGK1/Akt/mTOR signal pathway	20
Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis	20
Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors	20
Progress and application of circulating tumor cells in non-small cell lung cancer	20
CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells	20
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy	20
Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma	20
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response	20
Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma in vitro and in vivo	20
A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer	20
USMB-shMincle: a virus-free gene therapy for blocking M1/M2 polarization of tumor-associated macrophages	19
Circular RNAs act as regulators of autophagy in cancer	19
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma	19
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications	19
CRISPR-Cas knockout of miR21 reduces glioma growth	19
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq	19
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE	19
The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma	19
miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway	19
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer	18
Circular RNA circRAB31 acts as a miR-885-5p sponge to suppress gastric cancer progression via the PTEN/PI3K/AKT pathway	18
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35	18
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model	18
Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma	18
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer	18
lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis	18
Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling	17
CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway	17
Quantitative proteomics characterization of cancer biomarkers and treatment	17
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures	17
miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma	17
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models	17
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma	17
Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment	17
Intracranial delivery of synthetic mRNA to suppress glioblastoma	16
Upregulated CBX8 Promotes Cancer Metastasis via the WNK2/MMP2 Pathway	16
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy	16
CD47-targeted cancer immunogene therapy: Secreted SIRPα-Fc fusion protein eradicates tumors by macrophage and NK cell activation	16
Applications of nuclear-based imaging in gene and cell therapy: Probe considerations	16
Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer	16
Circular RNA SERPINE2 promotes development of glioblastoma by regulating the miR-361-3p/miR-324-5p/BCL2 signaling pathway	16
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer	16
Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer	16
SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition	15
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors	15
A one-step construction of adenovirus (OSCA) system using the Gibson DNA Assembly technology	15
In vivo CART cell imaging: Paving the way for success in CART cell therapy	15
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers	15
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis	15
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity	15
Comprehensive landscape of tRNA-derived fragments in lung cancer	15
Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells	15
Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity	15
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling	15
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation	15
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition	15
Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells	15
Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma	14
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma	14
R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway	14
Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma	14
Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors	14
Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2	14
UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis	14
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo	14
Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance	14
Current advances of liquid biopsies in prostate cancer: Molecular biomarkers	14
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment	14
DNA-methylation-induced silencing of DIO3OS drives non-small cell lung cancer progression via activating hnRNPK-MYC-CDC25A axis	14
Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL	13
Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer	13
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels	13
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1	13
Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma	13
Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy	13
Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody	13

Arming HSV-Based Oncolytic Viruses with the Ability to Redirect the Host’s Innate Antiviral Immunity to Attack Tumor Cells	13
circBANP promotes colorectal cancer growth and metastasis via sponging let-7d-5p to modulate HMGA1/Wnt/β-catenin signaling	13
Structure-based virtual screening identifies an 8-hydroxyquinoline as a small molecule GLI1 inhibitor	13
Cardamonin suppresses pro-tumor function of macrophages by decreasing M2 polarization on ovarian cancer cells via mTOR inhibition	13
S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression	12
Purple sweet potato delphinidin-3-rutin represses glioma proliferation by inducing miR-20b-5p/Atg7-dependent cytostatic autophagy	12
A library of cancer testis specific T cell receptors for T cell receptor gene therapy	12
Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma	12
miR-301 regulates the SIRT1/SOX2 pathway via CPEB1 in the breast cancer progression	12
Non-coding RNAs in melanoma: Biological functions and potential clinical applications	12
TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma	12
IL-13Rα2 humanized scFv-based CAR-T cells exhibit therapeutic activity against glioblastoma	12
Introducing a new reporter gene, membrane-anchored Cypridina luciferase, for multiplex bioluminescence imaging	12
Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy	12
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer	12
Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity	12
Emerging function and clinical significance of extracellular vesicle noncoding RNAs in lung cancer	12
E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms	12
Non-coding RNAs and glioma: Focus on cancer stem cells	12
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide	12
A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer	11
CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer	11
An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model	11
Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis	11
Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC	11
Hsa_circ_0001666 promotes non-small cell lung cancer migration and invasion through miR-1184/miR-548I/AGO1 axis	11
Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes	11
The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer	11
Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway	11
Anti-tumor immunity enhancement by photodynamic therapy with talaporfin sodium and anti-programmed death 1 antibody	11
Current development in adenoviral vectors for cancer immunotherapy	11
PROTACs in gastrointestinal cancers	11
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus	11
Improved lentiviral vector titers from a multi-gene knockout packaging line	11
hsa_circ_0085539 Promotes Osteosarcoma Progression by Regulating miR-526b-5p and SERP1	10
Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer	10
Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML	10
Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro	10
A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics	10
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory	10
Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors	10
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells	10
Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus	10
Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer	10
ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma	10
A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers	10
Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium	10
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition	10
Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model	9
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells	9
Local adenoviral delivery of soluble CD200R-Ig enhances antitumor immunity by inhibiting CD200-β-catenin-driven M2 macrophage	9
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML	9
Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation	9
Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer	9
LINC00461 facilitates HNSCC development and reduces chemosensitivity by impairing miR-195-mediated inhibition of HOXA10	9
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma	9
Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockade	9
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9	9
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy	9
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors	9
Efficient delivery of oncolytic enterovirus by carrier cell line NK-92	9
Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format	9
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?	9
Zika virus cleaves GSDMD to disseminate prognosticable and controllable oncolysis in a human glioblastoma cell model	9
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development	9
LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex	9
Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β	9
A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors	9
AAMP promotes colorectal cancer metastasis by suppressing SMURF2-mediated ubiquitination and degradation of RhoA	9
A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation	9
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus	9
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy	9
Knockdown of SENP1 inhibits HIF-1α SUMOylation and suppresses oncogenic CCNE1 in Wilms tumor	9
Metformin preferentially enhances the radio-sensitivity of cancer stem-like cells with highly mitochondrial respiration ability in HMPOS	9
Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC	9
Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model	8
miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition	8
Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma	8
Cholesterol-enriched membrane micro-domain deficiency induces doxorubicin resistance via promoting autophagy in breast cancer	8
A systematic analysis on the clinical safety and efficacy of onco-virotherapy	8
Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis	8
Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration	8
Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy	8
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10	8
Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA	8
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer	8
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo	8
Oleanolic acid blocks the purine salvage pathway for cancer therapy by inactivating SOD1 and stimulating lysosomal proteolysis	8
Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis	8
Remission of liquid tumors and SARS-CoV-2 infection: A literature review	8
The pivotal regulatory factor circBRWD1 inhibits arsenic exposure-induced lung cancer occurrence by binding mRNA and regulating its stability	8
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus	8